Integra LifeSciences Receives FDA Approval for Expanded Indications for Spine Device

Integra LifeSciences has received FDA approval for expanded indication for use of the Integra Vu aPOD Prime Intervertebral Body Fusion Device in anterior lumbar interbody fusion procedures.

Advertisement

The new stand-alone indication includes four points of fixation, which is composed of two screws and a SpinPlate. The Integra Vu aPOD Prime IBD features two zero-profile options utilizing two screws or two screws and a SpinPlate to help secure the IBD in its functional position, eliminating the need for supplemental fixation implants and reducing
the number of steps and implants required to perform an ALIF procedure.

More Articles on Orthopedic Devices:

Spinal Elements to Donate Allograft Proceeds to Charity

Medtronic Launches Complementary Instrument Set for BRYAN Cervical Disc

SkelRegen Forms With Focus on Musculoskeletal Care

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.